- Yale MS Center6 Devine StreetSte Suite 2BNorth Haven, CT 06473
Erin Longbrake, MD/PhD
Neurology, Multiple Sclerosis
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From physicians only
Titles
- Assistant Professor of Neurology
- Director, Fellowship Program, Multiple Sclerosis & Other Inflammatory Brain Disease
Education & Training
- Multiple Sclerosis FellowWashington University (2016)
- MSWashington University, Clinical Investigation (2016)
- ResidentWashington University (2013)
- InternWashington University (2010)
- MD/PhDThe Ohio State University (2009)
- BACedarville University, Biology (2001)
Additional Information
Honors & Recognitions
- Sylvia Lawry Fellow: National Multiple Sclerosis Society (2013)
- Alpha Omega Alpha: The Ohio State University (2009)
Publications
- Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Translational Research : The Journal Of Laboratory And Clinical Medicine 2021, 233: 144-161. PMID: 33515779, PMCID: PMC8184576, DOI: 10.1016/j.trsl.2021.01.009.
- Longbrake EE, Mao-Draayer Y, Cascione M, Zielinski T, Bame E, Brassat D, Chen C, Kapadia S, Mendoza JP, Miller C, Parks B, Xing D, Robertson D. Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity. Multiple Sclerosis (Houndmills, Basingstoke, England) 2021, 27: 883-894. PMID: 32716690, PMCID: PMC8023410, DOI: 10.1177/1352458520937282.
- Peters J, Alhasan S, Vogels CBF, Grubaugh ND, Farhadian S, Longbrake EE. MOG-associated encephalitis following SARS-COV-2 infection. Multiple Sclerosis And Related Disorders 2021, 50: 102857. PMID: 33647592, PMCID: PMC7900751, DOI: 10.1016/j.msard.2021.102857.
- Gardin T, Longbrake EE. The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events: Inducing or "Unmasking" Autoimmunity? Neurology 2021, 96: 733-734. PMID: 33727404, DOI: 10.1212/WNL.0000000000011812.
- Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL. Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases. Annals Of Clinical And Translational Neurology 2021, 8: 918-928. PMID: 33616290, PMCID: PMC8013889, DOI: 10.1002/acn3.51314.
- Gluck L, Hernandez AL, Wesley SF, Fulbright RK, Longbrake EE, Stathopoulos P. Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus. Journal Of The Neurological Sciences 2020, 416: 116993. PMID: 32593886, PMCID: PMC8023411, DOI: 10.1016/j.jns.2020.116993.
- Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Multiple Sclerosis And Related Disorders 2020, 44: 102296. PMID: 32585616, PMCID: PMC8023409, DOI: 10.1016/j.msard.2020.102296.
- Obeidat AZ, Jassam YN, Hua LH, Cutter G, Ford CC, Halper J, Lisak RP, Sicotte NL, Longbrake EE. Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States. Neurology 2020, 94: 495-500. PMID: 32107321, PMCID: PMC9246053, DOI: 10.1212/WNL.0000000000009096.
- Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Sex effects across the lifespan in women with multiple sclerosis. Therapeutic Advances In Neurological Disorders 2020, 13: 1756286420936166. PMID: 32655689, PMCID: PMC7331774, DOI: 10.1177/1756286420936166.
- Choileáin SN, Kleinewietfeld M, Raddassi K, Hafler DA, Ruff WE, Longbrake EE. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. Journal Of Translational Autoimmunity 2020, 3: 100032. PMID: 32743517, PMCID: PMC7388357, DOI: 10.1016/j.jtauto.2019.100032.
- Longbrake EE, Hafler DA. Siponimod Chips Away at Progressive MS. Cell 2019, 179: 1440. PMID: 31951523, PMCID: PMC8023412, DOI: 10.1016/j.cell.2019.11.034.
- Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT. Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS. Multiple Sclerosis (Houndmills, Basingstoke, England) 2018, 24: 1347-1355. PMID: 28766993, DOI: 10.1177/1352458517721357.
- Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count. Multiple Sclerosis (Houndmills, Basingstoke, England) 2018, 24: 728-738. PMID: 28480794, PMCID: PMC5665729, DOI: 10.1177/1352458517707069.
- Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I. Effectiveness of alternative dose fingolimod for multiple sclerosis. Neurology. Clinical Practice 2018, 8: 102-107. PMID: 29708225, PMCID: PMC5914753, DOI: 10.1212/CPJ.0000000000000434.
- Dominguez M, DiCapua D, Leydon G, Loomis C, Longbrake EE, Schaefer SM, Becker KP, Detyniecki K, Gottschalk C, Salardini A, Encandela JA, Moeller JJ. A Neurology Clerkship Curriculum Using Video-Based Lectures and Just-in-Time Teaching (JiTT). MedEdPORTAL : The Journal Of Teaching And Learning Resources 2018, 14: 10691. PMID: 30800891, PMCID: PMC6342385, DOI: 10.15766/mep_2374-8265.10691.
- Longbrake EE, Lancia S, Tutlam N, Trinkaus K, Naismith RT. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. Multiple Sclerosis And Related Disorders 2016, 10: 198-203. PMID: 27919490, PMCID: PMC5392253, DOI: 10.1016/j.msard.2016.10.009.
- Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology 2016, 87: 1393-9. PMID: 27581217, PMCID: PMC5047038, DOI: 10.1212/WNL.0000000000003152.
- Longbrake EE, Hafler DA. Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail. JAMA Neurology 2016, 73: 777-8. PMID: 27244583, PMCID: PMC5198230, DOI: 10.1001/jamaneurol.2016.1227.
- Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England) 2016, 22: 1061-1070. PMID: 26459150, PMCID: PMC4829494, DOI: 10.1177/1352458515608961.
- Wu GF, Longbrake EE. An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation 2016, 3: e218. PMID: 27110589, PMCID: PMC4830190, DOI: 10.1212/NXI.0000000000000218.
- Longbrake EE, Cross AH. Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity. JAMA Neurology 2016, 73: 219-25. PMID: 26720195, DOI: 10.1001/jamaneurol.2015.3977.
- Longbrake EE, Cross AH, Salter A. Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice. Multiple Sclerosis Journal - Experimental, Translational And Clinical 2016, 2 PMID: 28280599, PMCID: PMC5340186, DOI: 10.1177/2055217316677868.
- Longbrake EE, Cross AH. Dimethyl fumarate associated lymphopenia in clinical practice. Multiple Sclerosis (Houndmills, Basingstoke, England) 2015, 21: 796-7. PMID: 25432948, PMCID: PMC4426020, DOI: 10.1177/1352458514559299.
- Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance. Multiple Sclerosis Journal - Experimental, Translational And Clinical 2015, 1 PMID: 26550483, PMCID: PMC4636217, DOI: 10.1177/2055217315596994.
- Longbrake EE, Parks BJ, Cross AH. Monoclonal antibodies as disease modifying therapy in multiple sclerosis. Current Neurology And Neuroscience Reports 2013, 13: 390. PMID: 24027005, PMCID: PMC3967547, DOI: 10.1007/s11910-013-0390-z.
- Longbrake EE, Ances BM, Viets RB, Clifford DB. Susac syndrome in a patient with human immunodeficiency virus infection. Journal Of Neurovirology 2013, 19: 270-3. PMID: 23690260, PMCID: PMC4582780, DOI: 10.1007/s13365-013-0164-z.
- Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience 2011, 31: 9910-22. PMID: 21734283, PMCID: PMC3139517, DOI: 10.1523/JNEUROSCI.2114-11.2011.
- Longbrake EE, Racke MK. Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis? Expert Review Of Neurotherapeutics 2009, 9: 319-21. PMID: 19271940, DOI: 10.1586/14737175.9.3.319.
- Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Experimental Neurology 2008, 212: 337-47. PMID: 18511041, PMCID: PMC2600773, DOI: 10.1016/j.expneurol.2008.04.009.
- Holmes FE, Arnott N, Vanderplank P, Kerr NC, Longbrake EE, Popovich PG, Imai T, Combadière C, Murphy PM, Wynick D. Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. Journal Of Neurochemistry 2008, 106: 640-9. PMID: 18410510, PMCID: PMC2726982, DOI: 10.1111/j.1471-4159.2008.05419.x.
- Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nature Reviews. Neuroscience 2008, 9: 481-93. PMID: 18490917, DOI: 10.1038/nrn2398.
- Longbrake EE, Lai W, Ankeny DP, Popovich PG. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. Journal Of Neurochemistry 2007, 102: 1083-94. PMID: 17663750, DOI: 10.1111/j.1471-4159.2007.04617.x.
Locations
- Yale MS Center6 Devine StreetSte Suite 2BNorth Haven, CT 06473
Titles
- Assistant Professor of Neurology
- Director, Fellowship Program, Multiple Sclerosis & Other Inflammatory Brain Disease
Education & Training
- Multiple Sclerosis FellowWashington University (2016)
- MSWashington University, Clinical Investigation (2016)
- ResidentWashington University (2013)
- InternWashington University (2010)
- MD/PhDThe Ohio State University (2009)
- BACedarville University, Biology (2001)
Additional Information
Honors & Recognitions
- Sylvia Lawry Fellow: National Multiple Sclerosis Society (2013)
- Alpha Omega Alpha: The Ohio State University (2009)
Publications
- Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Translational Research : The Journal Of Laboratory And Clinical Medicine 2021, 233: 144-161. PMID: 33515779, PMCID: PMC8184576, DOI: 10.1016/j.trsl.2021.01.009.
- Longbrake EE, Mao-Draayer Y, Cascione M, Zielinski T, Bame E, Brassat D, Chen C, Kapadia S, Mendoza JP, Miller C, Parks B, Xing D, Robertson D. Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity. Multiple Sclerosis (Houndmills, Basingstoke, England) 2021, 27: 883-894. PMID: 32716690, PMCID: PMC8023410, DOI: 10.1177/1352458520937282.
- Peters J, Alhasan S, Vogels CBF, Grubaugh ND, Farhadian S, Longbrake EE. MOG-associated encephalitis following SARS-COV-2 infection. Multiple Sclerosis And Related Disorders 2021, 50: 102857. PMID: 33647592, PMCID: PMC7900751, DOI: 10.1016/j.msard.2021.102857.
- Gardin T, Longbrake EE. The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events: Inducing or "Unmasking" Autoimmunity? Neurology 2021, 96: 733-734. PMID: 33727404, DOI: 10.1212/WNL.0000000000011812.
- Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL. Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases. Annals Of Clinical And Translational Neurology 2021, 8: 918-928. PMID: 33616290, PMCID: PMC8013889, DOI: 10.1002/acn3.51314.
- Gluck L, Hernandez AL, Wesley SF, Fulbright RK, Longbrake EE, Stathopoulos P. Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus. Journal Of The Neurological Sciences 2020, 416: 116993. PMID: 32593886, PMCID: PMC8023411, DOI: 10.1016/j.jns.2020.116993.
- Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Multiple Sclerosis And Related Disorders 2020, 44: 102296. PMID: 32585616, PMCID: PMC8023409, DOI: 10.1016/j.msard.2020.102296.
- Obeidat AZ, Jassam YN, Hua LH, Cutter G, Ford CC, Halper J, Lisak RP, Sicotte NL, Longbrake EE. Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States. Neurology 2020, 94: 495-500. PMID: 32107321, PMCID: PMC9246053, DOI: 10.1212/WNL.0000000000009096.
- Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Sex effects across the lifespan in women with multiple sclerosis. Therapeutic Advances In Neurological Disorders 2020, 13: 1756286420936166. PMID: 32655689, PMCID: PMC7331774, DOI: 10.1177/1756286420936166.
- Choileáin SN, Kleinewietfeld M, Raddassi K, Hafler DA, Ruff WE, Longbrake EE. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. Journal Of Translational Autoimmunity 2020, 3: 100032. PMID: 32743517, PMCID: PMC7388357, DOI: 10.1016/j.jtauto.2019.100032.
- Longbrake EE, Hafler DA. Siponimod Chips Away at Progressive MS. Cell 2019, 179: 1440. PMID: 31951523, PMCID: PMC8023412, DOI: 10.1016/j.cell.2019.11.034.
- Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT. Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS. Multiple Sclerosis (Houndmills, Basingstoke, England) 2018, 24: 1347-1355. PMID: 28766993, DOI: 10.1177/1352458517721357.
- Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count. Multiple Sclerosis (Houndmills, Basingstoke, England) 2018, 24: 728-738. PMID: 28480794, PMCID: PMC5665729, DOI: 10.1177/1352458517707069.
- Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I. Effectiveness of alternative dose fingolimod for multiple sclerosis. Neurology. Clinical Practice 2018, 8: 102-107. PMID: 29708225, PMCID: PMC5914753, DOI: 10.1212/CPJ.0000000000000434.
- Dominguez M, DiCapua D, Leydon G, Loomis C, Longbrake EE, Schaefer SM, Becker KP, Detyniecki K, Gottschalk C, Salardini A, Encandela JA, Moeller JJ. A Neurology Clerkship Curriculum Using Video-Based Lectures and Just-in-Time Teaching (JiTT). MedEdPORTAL : The Journal Of Teaching And Learning Resources 2018, 14: 10691. PMID: 30800891, PMCID: PMC6342385, DOI: 10.15766/mep_2374-8265.10691.
- Longbrake EE, Lancia S, Tutlam N, Trinkaus K, Naismith RT. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. Multiple Sclerosis And Related Disorders 2016, 10: 198-203. PMID: 27919490, PMCID: PMC5392253, DOI: 10.1016/j.msard.2016.10.009.
- Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology 2016, 87: 1393-9. PMID: 27581217, PMCID: PMC5047038, DOI: 10.1212/WNL.0000000000003152.
- Longbrake EE, Hafler DA. Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail. JAMA Neurology 2016, 73: 777-8. PMID: 27244583, PMCID: PMC5198230, DOI: 10.1001/jamaneurol.2016.1227.
- Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England) 2016, 22: 1061-1070. PMID: 26459150, PMCID: PMC4829494, DOI: 10.1177/1352458515608961.
- Wu GF, Longbrake EE. An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis. Neurology® Neuroimmunology & Neuroinflammation 2016, 3: e218. PMID: 27110589, PMCID: PMC4830190, DOI: 10.1212/NXI.0000000000000218.
- Longbrake EE, Cross AH. Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity. JAMA Neurology 2016, 73: 219-25. PMID: 26720195, DOI: 10.1001/jamaneurol.2015.3977.
- Longbrake EE, Cross AH, Salter A. Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice. Multiple Sclerosis Journal - Experimental, Translational And Clinical 2016, 2 PMID: 28280599, PMCID: PMC5340186, DOI: 10.1177/2055217316677868.
- Longbrake EE, Cross AH. Dimethyl fumarate associated lymphopenia in clinical practice. Multiple Sclerosis (Houndmills, Basingstoke, England) 2015, 21: 796-7. PMID: 25432948, PMCID: PMC4426020, DOI: 10.1177/1352458514559299.
- Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance. Multiple Sclerosis Journal - Experimental, Translational And Clinical 2015, 1 PMID: 26550483, PMCID: PMC4636217, DOI: 10.1177/2055217315596994.
- Longbrake EE, Parks BJ, Cross AH. Monoclonal antibodies as disease modifying therapy in multiple sclerosis. Current Neurology And Neuroscience Reports 2013, 13: 390. PMID: 24027005, PMCID: PMC3967547, DOI: 10.1007/s11910-013-0390-z.
- Longbrake EE, Ances BM, Viets RB, Clifford DB. Susac syndrome in a patient with human immunodeficiency virus infection. Journal Of Neurovirology 2013, 19: 270-3. PMID: 23690260, PMCID: PMC4582780, DOI: 10.1007/s13365-013-0164-z.
- Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience 2011, 31: 9910-22. PMID: 21734283, PMCID: PMC3139517, DOI: 10.1523/JNEUROSCI.2114-11.2011.
- Longbrake EE, Racke MK. Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis? Expert Review Of Neurotherapeutics 2009, 9: 319-21. PMID: 19271940, DOI: 10.1586/14737175.9.3.319.
- Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Experimental Neurology 2008, 212: 337-47. PMID: 18511041, PMCID: PMC2600773, DOI: 10.1016/j.expneurol.2008.04.009.
- Holmes FE, Arnott N, Vanderplank P, Kerr NC, Longbrake EE, Popovich PG, Imai T, Combadière C, Murphy PM, Wynick D. Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. Journal Of Neurochemistry 2008, 106: 640-9. PMID: 18410510, PMCID: PMC2726982, DOI: 10.1111/j.1471-4159.2008.05419.x.
- Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nature Reviews. Neuroscience 2008, 9: 481-93. PMID: 18490917, DOI: 10.1038/nrn2398.
- Longbrake EE, Lai W, Ankeny DP, Popovich PG. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. Journal Of Neurochemistry 2007, 102: 1083-94. PMID: 17663750, DOI: 10.1111/j.1471-4159.2007.04617.x.
Locations
- Yale MS Center6 Devine StreetSte Suite 2BNorth Haven, CT 06473
- Yale MS Center6 Devine StreetSte Suite 2BNorth Haven, CT 06473